STL-201

N/A

Report date: 2022/05/10 11:53:18
NME

Base Information

Drug NameSTL-201
Drug Alias NameSTL201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrobiome modulators
TargetsUpdating
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStellate Therapeutics Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A